Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 30,041 | 31,106 | 2,751 | 1,899 | 1,992,371 |
| Cost of Goods | N/A | N/A | N/A | N/A | 993,237 |
| Gross Profit | 30,041 | 31,106 | 2,751 | 1,899 | 999,134 |
| Operating Expenses | 249,108 | 95,788 | 38,744 | 40,417 | 980,689 |
| Operating Income | -219,067 | -64,682 | -35,993 | -38,518 | 18,682 |
| Interest Expense | 33 | 3,900 | 5,293 | 1,514 | 14,087 |
| Other Income | -4,838 | -18,595 | -12,349 | 7,014 | 431 |
| Pre-tax Income | -223,938 | -87,177 | -53,635 | -33,018 | 5,026 |
| Income Tax | N/A | N/A | N/A | N/A | 7,043 |
| Net Income Continuous | -223,938 | -87,177 | -53,635 | -33,018 | -2,017 |
| Minority Interests | -678 | -44 | N/A | N/A | N/A |
| Net Income | $-223,260 | $-87,133 | $-53,635 | $-33,018 | $-2,017 |
| EPS Basic Total Ops | -6.01 | -10.64 | -16.10 | -15.85 | N/A |
| EPS Basic Continuous Ops | -6.03 | -10.65 | -16.10 | -15.85 | N/A |
| EPS Diluted Total Ops | -6.01 | -10.64 | -16.10 | -15.85 | N/A |
| EPS Diluted Continuous Ops | -6.03 | -10.65 | -16.10 | -15.85 | N/A |
| EBITDA(a) | $-217,198 | $-64,008 | $-35,589 | $-38,297 | $18,682 |